(Q34579324)

3 August 2017

title

A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia (English)

1 reference

3 August 2017

0 references

0 references

4

Michael F Green

1 reference

3 August 2017

1

Donald C Goff

1 reference

3 August 2017

7

Theo Manschreck

1 reference

3 August 2017

8

Oliver Freudenreich

1 reference

3 August 2017

J Steven Lamberti

2

1 reference

3 August 2017

Andrew C Leon

3

1 reference

3 August 2017

Alexander L Miller

5

1 reference

3 August 2017

Jayendra Patel

6

1 reference

3 August 2017

Steven A Johnson

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

9 May 2007

1 reference

3 August 2017

published in

Neuropsychopharmacology

1 reference

3 August 2017

volume

33

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

465-472

1 reference

Caution regarding the use of pilot studies to guide power calculations for study proposals

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

AMPA receptor potentiators for the treatment of CNS disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Chronic elevation of brain-derived neurotrophic factor by ampakines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

AMPA receptor trafficking and synaptic plasticity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Molecular mechanisms associated with long-term consolidation of the NMDA signals

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

D-serine added to clozapine for the treatment of schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Synergistic interactions between ampakines and antipsychotic drugs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

A synaptic model of memory: long-term potentiation in the hippocampus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Facilitation of glutamate receptors enhances memory

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

A rating scale for extrapyramidal side effects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

The positive and negative syndrome scale (PANSS) for schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

A rating scale for drug-induced akathisia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices

7 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Enhancement by an ampakine of memory encoding in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-aspartate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Antipsychotic drug regulation of AMPA receptor affinity states and GluR1, GluR2 splice variant expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Effects of chronic haloperidol and clozapine treatment on AMPA and kainate receptor binding in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

AMPA receptor modulators have different impact on hippocampal pyramidal cells and interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Differential regulation of hippocampal AMPA and kainate receptor subunit expression by haloperidol and clozapine.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Psychological effects of a drug that facilitates brain AMPA receptors.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Facilitation of olfactory learning by a modulator of AMPA receptors

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3098468

Neuropharmacology of AMPA and kainate receptors

27 October 2018

1 reference

12 December 2020

A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia

1 reference

12 December 2020

Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats

1 reference

12 December 2020

Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia

1 reference

12 December 2020

Glutamate receptor expression in schizophrenic brain

1 reference

12 December 2020

Placebo-controlled trial of glycine added to clozapine in schizophrenia

1 reference

12 December 2020

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

12 December 2020

SAFTEE: a technique for the systematic assessment of side effects in clinical trials

1 reference

12 December 2020

Reliability and validity of the positive and negative syndrome scale for schizophrenics

1 reference

12 December 2020

A depression rating scale for schizophrenics

1 reference

12 December 2020

Predicting premorbid IQ: A revision of the national adult reading test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301444

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.NPP.1301444

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference